These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1871054)

  • 41. Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.
    Schmidt EB; Illingworth DR; Bacon S; Mahley RW; Weisgraber KH
    Atherosclerosis; 1993 Jan; 98(2):213-7. PubMed ID: 8457260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on the in vitro binding of D-penicillamine to cholestyramine.
    Allgayer H; Kruis W; Paumgartner G
    Experientia; 1982 Apr; 38(4):482-4. PubMed ID: 7084416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acceptability of cholestyramine and colestipol formulations in three common vehicles.
    Ito MK; Morreale AP
    Clin Pharm; 1991 Feb; 10(2):138-40. PubMed ID: 2009732
    [No Abstract]   [Full Text] [Related]  

  • 44. Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins.
    Herman RJ; Chaudhary A; Szakacs CB; Woo D; Lane R; Boctor MA
    Eur J Clin Pharmacol; 1995; 48(3-4):253-8. PubMed ID: 7589050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical inquiry. Postcholecystectomy diarrhea: what relieves it?
    Danley T; St Anna L
    J Fam Pract; 2011 Oct; 60(10):632c-d. PubMed ID: 21977493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of renal impairment and hemodialysis on lorazepam kinetics.
    Morrison G; Chiang ST; Koepke HH; Walker BR
    Clin Pharmacol Ther; 1984 May; 35(5):646-52. PubMed ID: 6713774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of thermodynamic parameters for the activated charcoal-phenobarbitone adsorption system.
    Agarwal S; Pal TK
    Boll Chim Farm; 1999 Sep; 138(8):422-6. PubMed ID: 10622108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Modification-possibility of the enterohepatic circulation of digitoxin in man].
    Sattler RW; Schmiedeberg W; Seiler KU
    Arzneimittelforschung; 1977; 27(8):1615-7. PubMed ID: 578758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of bile salt-binding resins on the morphology of rat jejunum and colon. A scanning electron microscopy study.
    Cassidy MM; Lightfoot FG; Grau LE; Roy T; Story JA; Kritchevsky D; Vahouny GV
    Dig Dis Sci; 1980 Jul; 25(7):504-12. PubMed ID: 7389538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The acceptability of resin therapy to patients attending a hospital lipid clinic.
    Iversen SA; Davidson D; Davidson C
    Br J Clin Pharmacol; 1995 Jul; 40(1):92-4. PubMed ID: 8527276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The adsorption of bile salts on activated carbon.
    Krasopoulos JC; De Bari VA; Needle MA
    Lipids; 1980 May; 15(5):365-70. PubMed ID: 7392829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro study of oxytetracycline adsorption on activated charcoal.
    Alegakis AK; Tzatzarakis MN; Tsatsakis AM; Vlachonikolis IG; Liakou V
    J Environ Sci Health B; 2000 Sep; 35(5):559-69. PubMed ID: 10968607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeated doses of activated charcoal and cholestyramine for digitoxin overdose: pharmacokinetic data and urinary elimination.
    Hantson P; Vandenplas O; Mahieu P; Wallemacq P; Hassoun A
    J Toxicol Clin Exp; 1991 Dec; 11(7-8):401-5. PubMed ID: 1841076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mathematical model and dimensional analysis of glycocholate binding to cholestyramine resin: implications for in vivo resin performance.
    Polli JE; Amidon GL
    J Pharm Sci; 1995 Dec; 84(12):1446-54. PubMed ID: 8748328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of absorption of paracetamol by activated charcoal and cholestyramine: a possible therapeutic measure.
    Dordoni B; Willson RA; Thompson RP; Williams R
    Br Med J; 1973 Jul; 3(5871):86-7. PubMed ID: 4717848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ask the Pharmacist.
    McGurrey E
    Am Pharm; 1992 Sep; NS32(9):24. PubMed ID: 1442550
    [No Abstract]   [Full Text] [Related]  

  • 57. In-vitro adsorption studies of isoniazid.
    Orisakwe OE; Akintonwa A
    Hum Exp Toxicol; 1991 Mar; 10(2):133-5. PubMed ID: 1675105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption.
    Faruqui AM; Thurmond MS; Wenger J; Wenger NK
    J Pak Med Assoc; 1981 Nov; 31(11):241-5. PubMed ID: 6802993
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of cholestyramine in the treatment of digoxin intoxication.
    Henderson RP; Solomon CP
    Arch Intern Med; 1988 Mar; 148(3):745-6. PubMed ID: 3341874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypolipidemic agents and gallstones.
    Med Lett Drugs Ther; 1977 Jun; 19(11):46. PubMed ID: 865410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.